Why is Court Pointing Fingers at Us? Patanjali MD Filed a Plea Against IMA MD’s Remarks on SC

The Managing Director of Patanjali Ayurveda, Acharya Balkrishna, filed a plea against the President of the Indian Medical Association (IMA), Dr. RV Asokan, for disparaging remarks about the Supreme Court. This arises from the Court’s criticism of IMA’s unethical practices. Simultaneously, the Supreme Court is hearing a petition by IMA against Patanjali Ayurveda for misleading advertisements.

“What Have You Done in Nine Months Since Taking Over?” SC After Uttarakhand Cancels 14 Patanjali Licences

Today (30th April): The Supreme Court rebuked the Uttarakhand State Licensing Authority for inaction in a case involving misleading advertisements by Patanjali Ayurveda. The court criticized Patanjali for non-compliance with its orders but appreciated the improvement in their actions after issuing a public apology. The court highlighted the need for caution and responsible advertising practices.

[BREAKING] ‘Is Apology Same Size as Your Ads?’: SC to Ramdev

Ramdev-Patanjali Ayurved, Today (April 23rd) during a hearing in the Supreme Court over the misleading ads, said it had published an apology in 67 newspapers, asserting it had the utmost respect for the court and their mistakes would not be repeated. Court asked if the size of the apology put out in newspapers by Patanjali was similar to full-page advertisements for its products.

BREAKING | Patanjali Issues Apology Ahead of Ramdev’s Court Appearance Today

Hours ahead of a Supreme Court hearing Today (April 23rd) in the misleading ads case against it, Patanjali Ayurved today put out an apology in a national daily, stressing that they have utmost respect for the court and that their mistakes will not be repeated.

“Pay Rs 4.5 Cr Tax for Charging Entry Fees at Yoga Camps”: Supreme Court Orders Ramdev’s Patanjali Trust

The Supreme Court upheld the CESTAT ruling and held that Ramdev’s Patanjali Yogpeeth Trust is liable to pay Rs 4.95 crore to tax authorities for Yoga camps.

“Happened out of excitement, won’t repeat”: Ramdev | SC Grants Patanjali 1-Week for Public Apology

Today(on 16th April), The Supreme Court of India engaged with Patanjali promoters, Baba Ramdev and Acharya Balkrishna, to assess their sincerity over misleading ads disparaging modern medicine. The apology was deemed insufficient, and the case is adjourned till April 23 for further commitment demonstration. The Indian Medical Association filed the plea, citing a smear campaign against modern medicine and COVID-19 vaccination efforts.

BREAKING | Ramdev and Associate Issue Public Apology in Supreme Court Over Misleading Ads Case

Yoga guru Ramdev and his aide Balkrishna are in the Supreme Court Today (April 16th) as it hears the contempt case against Patanjali Ayurved in connection with its misleading ads and Covid cure claims. The court had come down heavily on the Patanjali founders during the previous hearing last week.

IMA vs. UOI | Supreme Court Levies Rs.10,000 Fine on Intervention Applicant for Alleged Proxy Litigation in ‘Patanjali Case’

The Supreme Court fined an intervention applicant Rs.10,000 for attempting to join a case against Patanjali Ayurved with misleading claims. The applicant alleged a quack doctor’s role in their mother’s death, but the court dismissed the application, warning against manipulating the legal process. Patanjali faced criticism for misleading advertisements and offered an unconditional apology.

“We will Rip You Apart”, Inappropriate Remark by Supreme Court Judge Questions on “Judicial Decorum and Conduct”

New delhi: The recent statement “We will rip you apart” by Justice Ahsanuddin Amanullah sparked a debate about judicial decorum. Judges expressed concern over the appropriateness of such language for a high judicial position, citing the need for impartial discussions and maintaining sobriety in court proceedings. Past rulings emphasize the high standards of behavior expected from judges.

“Mercy for One, But What About the Rest”: SC Plight of Faceless Individuals Relying on Misleading Medication

On Wednesday (10th April): The Supreme Court of India expressed concern for public well-being, particularly regarding misleading advertisements and unregulated products. Justices emphasized that violations of the law, such as exploiting people’s trust with misleading claims, will not be tolerated. This relates to a recent contempt plea against Patanjali for marketing its product, Coronil, as a COVID-19 cure, violating drug advertising regulations.